C38.4
Malignant neoplasm of pleura
Clinical Classification Guidelines
Medical Intelligence & Overview
Malignant neoplasm of the pleura, commonly known as pleural cancer, is a serious condition characterized by the growth of cancerous cells in the lining surrounding the lungs. This lining, called the pleura, plays a vital role in facilitating lung movement during breathing. The disease is often associated with prolonged asbestos exposure and can significantly impact respiratory health. Recognizing the symptoms and understanding the causes, diagnosis, and treatment options are essential steps in managing this condition effectively.
Causes & Symptoms
Clinical Causes: Prolonged exposure to asbestos fibers, a primary risk factor Previous radiation therapy to the chest area Certain genetic predispositions, though less common History of other asbestos-related diseases, such as asbestosis Environmental exposure to asbestos in the workplace or environment
Key Symptoms: Chest pain that worsens over time Persistent cough that does not improve Shortness of breath or difficulty breathing Unexplained weight loss and fatigue Fever and night sweats in some cases Pleural effusion (accumulation of fluid around the lungs)
Diagnostic & Treatment
Diagnosis Path: Imaging tests such as chest X-ray, CT scan, or PET scan to identify tumors or fluid buildup Thoracentesis to extract pleural fluid for laboratory analysis Biopsy procedures including needle biopsy or thoracoscopy to obtain tissue samples for histopathological examination Blood tests to assess overall health and detect tumor markers in some cases Assessment of patient history, especially occupational exposure history
Treatment Protocols: Surgical removal of tumor tissue when feasible, such as pleurectomy or extrapleural pneumonectomy Chemotherapy to target cancer cells and slow disease progression Radiation therapy aimed at shrinking tumors and alleviating symptoms Palliative care to improve quality of life, manage symptoms, and provide supportive therapies Emerging treatments like immunotherapy and targeted drug therapies are being studied for their potential benefits
Clinical Advice & FAQs
Billing Guidance
Is C38.4 a billable ICD-10 code?
Yes, C38.4 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C38.4?
Clinical documentation must specify the nature of Malignant neoplasm of pleura and any associated comorbidities for accurate reporting.
Cite this Clinical Reference